SEOUL, South Korea, Sept. 17, 2021 /PRNewswire/ — KGC (Korea Ginseng Corp), which makes the No. 1 red ginseng brand, CheongKwanJang in Korea, announced that the most popular Chuseok gift in Korea is red ginseng. The announcement was based on Korea Health Supplements Association. According to the association, the healthContinue Reading
The ‘Virtual Card Number’ allows Traveloka users to transact on e-commerce platforms outside the Traveloka ecosystem, and introduces the option of installment payment methods utilizing the user’s PayLater credit limit. As the pioneer of the PayLater payment method in Indonesia, the Traveloka PayLater ‘Virtual Card Number’ is another example ofContinue Reading
HONG KONG, Sept. 17, 2021 /PRNewswire/ — “Dubbing Academy”, jointly organised by the Greater Bay Area Homeland Youth Community Foundation (Greater Bay Area Youth Foundation) and the Television Broadcasting Limited (TVB), provided a free professional dubbing experiential course to Hong Kong youths who wish to pursue a career in the dubbing industryContinue Reading
The first App for Thai investors to invest directly in offshore mutual funds from 33 local and global asset management companies SINGAPORE, Sept. 17, 2021 /PRNewswire/ — Lu International (Singapore) Financial Asset Exchange Pte. Ltd. (“Lu International”), a subsidiary of China’s leading technology-empowered personal financial services platform Lufax Holding (NYSE: LU),Continue Reading
Sugemalimab is the world’s first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients with stage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy The data showed that sugemalimab demonstrated a statistically significant and clinically meaningful improvement in the Blinded Independent CentralContinue Reading
SAN FRANCISCO and SUZHOU, China, Sept. 17, 2021 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that the results of the Phase 2 study in Chinese patientsContinue Reading
SHANGHAI, Sept. 17, 2021 /PRNewswire/ — Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today that it will expand its exclusive license agreement with Eyenovia, Inc. (NASDAQ: EYEN) to include a third asset, MydCombi™, for development and commercialization in Greater China (mainland China, Hong Kong, MacauContinue Reading
Collaboration consolidates Everest’s leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $549 million in total development, regulatory, and commercial milestone payments SHANGHAI, Sept. 17, 2021 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”) announced today that it has entered intoContinue Reading
International CRM software provider, Really Simple Systems, releases a new integration with Microsoft 365 for contacts and calendars. PETERSFIELD, England, Sept. 17, 2021 /PRNewswire/ — Leading cloud software developer and vendor, Really Simple Systems, has launched of a new integration between its popular CRM and Microsoft 365, enhancing its platformContinue Reading
Pre-clinical data exploring the in vitro and in vivo efficacy of BBT-176 will be disclosed via an ePoster at the ESMO Congress 2021 Patient dosing for the phase 1/2 clinical study of BBT-176 was initiated in April 2021…the topline data of the first-in-human, dose escalation study is expected to beContinue Reading